Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats. 1984

B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich

The effects of immediate (1 h) and prolonged (3 weeks) treatment with nitrendipine on systemic and regional hemodynamics were investigated in Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats. Mean arterial pressure (MAP) was significantly (p less than 0.05) decreased in both WKY (125 +/- 2 versus 108 +/- 3 mm Hg) and SHR (189 +/- 5 versus 141 +/- 10 mm Hg) 1 h following oral nitrendipine administration (10 mg/kg). This was associated with a significant (p less than 0.05) decrease in total peripheral resistance index (TPRI) (0.48 +/- 0.03 versus 0.38 +/- 0.02 units/kg, WKY; 0.69 +/- 0.04 versus 0.56 +/- 0.05 units/kg SHR) but no change in cardiac index (CI). A significant (p less than 0.05) increase in heart rate (HR) (374 +/- 14 versus 407 +/- 11 beats/min) was observed only in WKY. Vascular resistances were reduced significantly (p less than 0.05) in heart and kidney in both SHR and WKY as well as the brain and splanchnic organs of the WKY. Resistance increased significantly in SHR skin. The MAP reduction with prolonged treatment (196 +/- 3 versus 181 +/- 4 and 150 +/- 5 mm Hg) was also associated with a reduced TPRI (0.73 +/- 0.03 versus 0.64 +/- 0.07 and 0.50 +/- 0.03 units/kg) in SHR treated for 3 weeks with nitrendipine (10 and 20 mg/kg/day, respectively). No changes in systemic hemodynamics were observed in similarly treated WKY. Skeletal muscle and splanchnic vascular resistances were reduced (p less than 0.05) in nitrendipine-treated WKY (20 mg/kg/day).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D009568 Nitrendipine A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. Balminil,Bay e 5009,Bayotensin,Baypresol,Baypress,Gericin,Jutapress,Nidrel,Niprina,Nitre AbZ,Nitre-Puren,Nitregamma,Nitren 1A Pharma,Nitren Lich,Nitren acis,Nitrend KSK,Nitrendepat,Nitrendi Biochemie,Nitrendidoc,Nitrendimerck,Nitrendipin AL,Nitrendipin Apogepha,Nitrendipin Atid,Nitrendipin Basics,Nitrendipin Heumann,Nitrendipin Jenapharm,Nitrendipin Lindo,Nitrendipin Stada,Nitrendipin beta,Nitrendipin-ratiopharm,Nitrendipino Bayvit,Nitrendipino Ratiopharm,Nitrensal,Nitrepress,Tensogradal,Trendinol,Vastensium,nitrendipin von ct,nitrendipin-corax,Nitre Puren,NitrePuren,Nitrendipin ratiopharm,Nitrendipinratiopharm,nitrendipin corax,nitrendipincorax
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium

Related Publications

B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
February 1999, Alcoholism, clinical and experimental research,
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
January 1985, Clinical and experimental hypertension. Part A, Theory and practice,
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
May 1986, Hypertension (Dallas, Tex. : 1979),
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
September 2018, Hypertension (Dallas, Tex. : 1979),
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
June 1981, Acta physiologica Scandinavica,
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
October 1997, Journal of cardiovascular pharmacology,
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
December 1983, Japanese journal of pharmacology,
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
January 1984, Journal of cardiovascular pharmacology,
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
July 1971, Acta physiologica Scandinavica,
B L Pegram, and I Kobrin, and S Sesoko, and E D Frohlich
January 1998, Fundamental & clinical pharmacology,
Copied contents to your clipboard!